The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: GJB2 vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_004004.6(GJB2):c.23C>T (p.Thr8Met)

CA6904332

379889 (ClinVar)

Gene: GJB2
Condition: nonsyndromic genetic deafness
Inheritance Mode: Autosomal recessive inheritance
UUID: 8756501e-0855-4fe3-9e70-64b3569c122e
Approved on: 2025-01-15
Published on: 2025-03-18

HGVS expressions

NM_004004.6:c.23C>T
NM_004004.6(GJB2):c.23C>T (p.Thr8Met)
NC_000013.11:g.20189559G>A
CM000675.2:g.20189559G>A
NC_000013.10:g.20763698G>A
CM000675.1:g.20763698G>A
NC_000013.9:g.19661698G>A
NG_008358.1:g.8417C>T
ENST00000382844.2:c.23C>T
ENST00000382848.5:c.23C>T
ENST00000382844.1:c.23C>T
ENST00000382848.4:c.23C>T
NM_004004.5:c.23C>T
More

Uncertain Significance

Met criteria codes 2
PM3 PS3_Supporting
Not Met criteria codes 6
BA1 PP3 PP2 PM2 BS1 BP4

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hearing Loss Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CDH23, COCH, GJB2, KCNQ4, MYO6, MYO7A, SLC26A4, TECTA and USH2A Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hearing Loss VCEP
The c.23C>T variant in GJB2 is a missense variant predicted to cause substitution of threonine by methionine at amino acid 8. The filtering allele frequency (the lower threshold of the 95% CI of 75/91084, 1 homozygote) of this variant is 0.06728% in the South Asian chromosomes by gnomAD v4.1.0, which is neither above nor below the thresholds defined by the ClinGen HL EP for autosomal recessive conditions (PM2_Supporting, BS1, and BA1 not met). The computational predictor REVEL gives a score of 0.632, which is neither above nor below the thresholds predicting a damaging or benign impact on GJB2 function. Dual whole cell voltage clamp and dye transfer assays in HeLa cells demonstrated that even though potassium permeability remains the same in the variant, there is a reduction in cationic and large molecules dye transfer compared to WT (PMID:18684989) (PS3_Supporting). This variant has been detected in at least two individuals with autosomal recessive NSHL. One was compound heterozygous for the variant and a pathogenic variant, c.109G>A (p.Val37Ile), with phase unknown (0.5 PM3 points, PMID: 22384008). One individual was homozygous for the variant (0.5 PM3 points, PMID: 31162818) (PM3). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal recessive nonsyndromic genetic hearing loss based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: PM3, PS3_Supporting (Hearing Loss VCEP specifications version 2; 01/15/2025).
Met criteria codes
PM3
This variant has been detected in at least two individuals with autosomal recessive NSHL. One was compound heterozygous for the variant and a pathogenic variant, c.109G>A (p.Val37Ile), with phase unknown (0.5 PM3 points, PMID: 22384008). One individual was homozygous for the variant (0.5 PM3 points, PMID: 31162818) (PM3).
PS3_Supporting
Dual whole cell voltage clamp and dye transfer assays in HeLa cells demonstrated that even though potassium permeability remains the same in the variant, there is a reduction in cationic and large molecules dye transfer compared to WT (PMID:18684989) (PS3_Supporting).

Not Met criteria codes
BA1
The filtering allele frequency (the lower threshold of the 95% CI of 75/91084, 1 homozygote) of this variant is 0.06728% in the South Asian chromosomes by gnomAD v4.1.0, which is neither above nor below the thresholds defined by the ClinGen HL EP for autosomal recessive conditions (PM2_Supporting, BS1, and BA1 not met).
PP3
The computational predictor REVEL gives a score of 0.632, which is neither above nor below the thresholds predicting a damaging or benign impact on GJB2 function.
PP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2
The filtering allele frequency (the lower threshold of the 95% CI of 75/91084, 1 homozygote) of this variant is 0.06728% in the South Asian chromosomes by gnomAD v4.1.0, which is neither above nor below the thresholds defined by the ClinGen HL EP for autosomal recessive conditions (PM2_Supporting, BS1, and BA1 not met).
BS1
The filtering allele frequency (the lower threshold of the 95% CI of 75/91084, 1 homozygote) of this variant is 0.06728% in the South Asian chromosomes by gnomAD v4.1.0, which is neither above nor below the thresholds defined by the ClinGen HL EP for autosomal recessive conditions (PM2_Supporting, BS1, and BA1 not met).
BP4
The computational predictor REVEL gives a score of 0.632, which is neither above nor below the thresholds predicting a damaging or benign impact on GJB2 function.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.